Multiple Sclerosis Affects the Central Nervous System
Multiple sclerosis is a chronic autoimmune disorder that primarily affects the central nervous system (CNS), including the brain, spinal cord, and optic nerves, causing demyelination, inflammation, and neurodegeneration 1.
Primary CNS Involvement
The disease fundamentally targets the CNS through immune-mediated attack on myelin, the protective covering of nerve fibers. According to the most recent 2024 McDonald diagnostic criteria, MS diagnosis relies on demonstrating typical lesions in specific CNS anatomical locations 2:
- Periventricular regions (≥3 lesions required)
- Juxtacortical/cortical areas
- Infratentorial regions
- Spinal cord
- Optic nerves (newly included in 2024 criteria)
The 2024 MAGNIMS-CMSC-NAIMS consensus now recognizes the optic nerve as a fifth anatomical location for diagnosis, acknowledging that optic neuritis occurs in 20-31% of patients at presentation 3. This represents a critical update, as optic nerve involvement can be demonstrated through MRI showing increased T2 signal, gadolinium enhancement, or optic nerve swelling 3.
Clinical Manifestations of CNS Damage
The CNS damage produces characteristic neurological symptoms 1:
- Vision problems (from optic nerve demyelination)
- Sensory disturbances
- Muscle weakness
- Balance difficulties
- Bladder dysfunction
- Cognitive impairment and psychiatric symptoms
Emerging Evidence of Peripheral Nervous System Involvement
While MS is traditionally defined as a CNS disease, emerging evidence suggests the peripheral nervous system (PNS) can also be affected, though this remains secondary to the primary CNS pathology 4, 5.
Autonomic Nervous System Dysfunction
The autonomic nervous system shows functional involvement in MS patients 4, 6:
- Sudomotor dysfunction measurable by quantitative sudomotor axon reflex testing (QSART)
- Cardiovascular autonomic alterations causing orthostatic intolerance
- Bladder and bowel dysfunction
- Sexual dysfunction
- Sympathetic nervous system downregulation 7
However, these autonomic symptoms likely represent CNS control center damage rather than primary PNS disease 6. The clinical relevance varies—bladder, bowel, and sexual dysfunction are highly distressing, while cardiovascular autonomic changes have unclear clinical significance 6.
Important Clinical Caveats
The PNS involvement in MS should not be confused with primary demyelinating PNS disorders. While pathology studies have reported signs of PNS demyelination in some MS patients 4, 5, MS remains fundamentally a CNS disease. The PNS findings may suggest MS exists on a spectrum of demyelinating disorders rather than as a completely distinct entity 5, but this does not change the primary CNS focus of diagnosis and treatment.
Diagnostic Implications
The 2024 diagnostic criteria emphasize that MRI assessment should always cover both brain and spinal cord and now include susceptibility-sensitive sequences to detect the central vein sign and paramagnetic rim lesions, which are pathologically specific markers of MS 2. This comprehensive CNS imaging approach, combined with exclusion of alternative diagnoses (including MOGAD and AQP4+ NMOSD), remains the cornerstone of accurate MS diagnosis.